Official Information Act Request – Funding, Distribution, and Legal Framework of Puberty Blockers
Yasir Shaikh made this Official Information request to Ministry of Health
Currently waiting for a response from Ministry of Health, they must respond promptly and normally no later than (details and exceptions).
From: Yasir Shaikh
Dear Ministry of Health,
Subject: Official Information Act Request – Funding, Distribution, and Legal Framework of Puberty Blockers
Under the Official Information Act 1982, I respectfully request the following information:
Funding Details:
The total amount of taxpayer money allocated for the procurement and distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.
Distribution in Educational Institutions:
Are puberty blockers administered or distributed within educational institutions, including primary and secondary schools, as well as colleges?
If so, please provide details on the policies and protocols governing their administration in these settings.
Clinical Guidelines and Oversight:
What clinical guidelines does the Ministry of Health follow regarding the prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty blockers among youth?
Adverse Effects and Reporting:
Have there been any reported adverse effects or complications associated with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in response.
Informed Consent:
What processes are in place to ensure that minors and their guardians provide informed consent before initiating treatment with puberty blockers?
Legal Framework:
Since which year have puberty blockers been legally administered to the public in New Zealand?
Under which laws or regulations are healthcare providers authorized to prescribe and administer puberty blockers?
If any part of my request is unclear or requires further clarification, please do not hesitate to contact me.
Thank you for your attention to this matter. I look forward to your response within the statutory timeframe.
Yours sincerely,
Yasir Shaikh
From: OIA Requests
Kia ora
Thank you for your request for official information. The reference number
for your request is: H2024055740
As required under the Official Information Act 1982, The Ministry of
Health will endeavour to respond to your request no later than 20 working
days after the day your request was received. If you'd like to calculate
the timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/
If you have any queries, please feel free to contact the OIA Services Team
on [2][email address]. If any additional factors come to light which
are relevant to your request, please do not hesitate to contact us so that
these can be taken into account.
Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [3][email address] or by calling 0800
802 602.
Ngā mihi
OIA Services Team
[4]Ministry of Health information releases
------------------- Original Message -------------------
From: Yasir Shaikh <[FOI #29139 email]>;
Received: Mon Nov 11 2024 12:40:33 GMT+1300 (New Zealand Daylight Time)
To: OIA Requests <[email address]>; OIA <[email address]>;
Subject: Official Information request - Official Information Act Request –
Funding, Distribution, and Legal Framework of Puberty Blockers
Dear Ministry of Health,
Subject: Official Information Act Request – Funding, Distribution, and
Legal Framework of Puberty Blockers
Under the Official Information Act 1982, I respectfully request the
following information:
Funding Details:
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.
Distribution in Educational Institutions:
Are puberty blockers administered or distributed within educational
institutions, including primary and secondary schools, as well as
colleges?
If so, please provide details on the policies and protocols governing
their administration in these settings.
Clinical Guidelines and Oversight:
What clinical guidelines does the Ministry of Health follow regarding the
prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty
blockers among youth?
Adverse Effects and Reporting:
Have there been any reported adverse effects or complications associated
with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in
response.
Informed Consent:
What processes are in place to ensure that minors and their guardians
provide informed consent before initiating treatment with puberty
blockers?
Legal Framework:
Since which year have puberty blockers been legally administered to the
public in New Zealand?
Under which laws or regulations are healthcare providers authorized to
prescribe and administer puberty blockers?
If any part of my request is unclear or requires further clarification,
please do not hesitate to contact me.
Thank you for your attention to this matter. I look forward to your
response within the statutory timeframe.
Yours sincerely,
Yasir Shaikh
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
References
Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. mailto:[email address]
4. https://www.health.govt.nz/about-ministr...
hide quoted sections
From: OIA Requests
Tçnâ koe Yasir,
Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health-Manatû Hauora on 11 November 2024.
The Ministry does not hold any information relating to the first two
questions of your request;
"Funding Details:
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this
period."
However, I have been advised that this information is held by Health New
Zealand (Te Whatu Ora). For this reason, I have decided to transfer your
request to Health New Zealand under section 14(b)(i) of the Act. You can
expect a response to these questions from their agency in due course.
Their contact email is: [1][email address].
The Ministry will respond to the rest of your request in due course.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.
Ngâ mihi
OIA Services Team
Manatû Hauora | Ministry of Health
M[3]inistry of Health information releases
--------------------------------------------------------------------------
From: Yasir Shaikh <[FOI #29139 email]>
Sent: Monday, 11 November 2024 12:38
To: OIA Requests <[email address]>
Subject: Official Information request - Official Information Act Request –
Funding, Distribution, and Legal Framework of Puberty Blockers
Dear Ministry of Health,
Subject: Official Information Act Request – Funding, Distribution, and
Legal Framework of Puberty Blockers
Under the Official Information Act 1982, I respectfully request the
following information:
Funding Details:
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.
Distribution in Educational Institutions:
Are puberty blockers administered or distributed within educational
institutions, including primary and secondary schools, as well as
colleges?
If so, please provide details on the policies and protocols governing
their administration in these settings.
Clinical Guidelines and Oversight:
What clinical guidelines does the Ministry of Health follow regarding the
prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty
blockers among youth?
Adverse Effects and Reporting:
Have there been any reported adverse effects or complications associated
with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in
response.
Informed Consent:
What processes are in place to ensure that minors and their guardians
provide informed consent before initiating treatment with puberty
blockers?
Legal Framework:
Since which year have puberty blockers been legally administered to the
public in New Zealand?
Under which laws or regulations are healthcare providers authorized to
prescribe and administer puberty blockers?
If any part of my request is unclear or requires further clarification,
please do not hesitate to contact me.
Thank you for your attention to this matter. I look forward to your
response within the statutory timeframe.
Yours sincerely,
Yasir Shaikh
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #29139 email]
Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[4]https://aus01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[5]https://aus01.safelinks.protection.outlo...
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.
-------------------------------------------------------------------
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
References
Visible links
1. mailto:[email address]
mailto:[email address]
2. mailto:[email address]
mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
4. https://fyi.org.nz/change_request/new?bo...
5. https://fyi.org.nz/help/officers
hide quoted sections
From: OIA Requests
Kia ora Yasir,
Further to the below email, the Ministry is also transferring the below
questions to Health New Zealand - Te Whatu Ora to respond. As such you can
expect a response to these questions from their agency in due course.
Their contact email is: [1][email address].
“"Funding Details:
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.
Distribution in Educational Institutions
Are puberty blockers administered or distributed within educational
institutions, including primary and secondary schools, as well as
colleges?
If so, please provide details on the policies and protocols governing
their administration in these settings.
Clinical Guidelines and Oversight
What clinical guidelines does the Ministry of Health follow regarding the
prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty
blockers among youth?
The Ministry will respond to the rest of your request in due course.
Adverse Effects and Reporting:
Have there been any reported adverse effects or complications associated
with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in
response.
Informed Consent:
What processes are in place to ensure that minors and their guardians
provide informed consent before initiating treatment with puberty
blockers?
Legal Framework:
Since which year have puberty blockers been legally administered to the
public in New Zealand?
Under which laws or regulations are healthcare providers authorized to
prescribe and administer puberty blockers?
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.
Ngâ mihi
OIA Services Team
Manatû Hauora | Ministry of Health
M[3]inistry of Health information releases
--------------------------------------------------------------------------
From: OIA Requests <[email address]>
Sent: Friday, 15 November 2024 15:47
To: Yasir Shaikh <[FOI #29139 email]>
Subject: Partial transfer of your request for official information, ref:
H2024055740 CRM:0121172
Tçnâ koe Yasir,
Thank you for your request under the Official Information Act 1982 (the
Act) to the Ministry of Health-Manatû Hauora on 11 November 2024.
The Ministry does not hold any information relating to the first two
questions of your request;
"Funding Details:
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this
period."
However, I have been advised that this information is held by Health New
Zealand (Te Whatu Ora). For this reason, I have decided to transfer your
request to Health New Zealand under section 14(b)(i) of the Act. You can
expect a response to these questions from their agency in due course.
Their contact email is: [4][email address].
The Ministry will respond to the rest of your request in due course.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [5][email address] or by calling 0800
802 602.
Ngâ mihi
OIA Services Team
Manatû Hauora | Ministry of Health
M[6]inistry of Health information releases
--------------------------------------------------------------------------
From: Yasir Shaikh <[FOI #29139 email]>
Sent: Monday, 11 November 2024 12:38
To: OIA Requests <[email address]>
Subject: Official Information request - Official Information Act Request –
Funding, Distribution, and Legal Framework of Puberty Blockers
Dear Ministry of Health,
Subject: Official Information Act Request – Funding, Distribution, and
Legal Framework of Puberty Blockers
Under the Official Information Act 1982, I respectfully request the
following information:
Funding Details:
The total amount of taxpayer money allocated for the procurement and
distribution of puberty blockers in New Zealand over the past five years.
A breakdown of annual expenditures on puberty blockers during this period.
Distribution in Educational Institutions:
Are puberty blockers administered or distributed within educational
institutions, including primary and secondary schools, as well as
colleges?
If so, please provide details on the policies and protocols governing
their administration in these settings.
Clinical Guidelines and Oversight:
What clinical guidelines does the Ministry of Health follow regarding the
prescription and administration of puberty blockers to minors?
What oversight mechanisms are in place to monitor the use of puberty
blockers among youth?
Adverse Effects and Reporting:
Have there been any reported adverse effects or complications associated
with the use of puberty blockers in minors over the past five years?
If so, please provide a summary of these reports and any actions taken in
response.
Informed Consent:
What processes are in place to ensure that minors and their guardians
provide informed consent before initiating treatment with puberty
blockers?
Legal Framework:
Since which year have puberty blockers been legally administered to the
public in New Zealand?
Under which laws or regulations are healthcare providers authorized to
prescribe and administer puberty blockers?
If any part of my request is unclear or requires further clarification,
please do not hesitate to contact me.
Thank you for your attention to this matter. I look forward to your
response within the statutory timeframe.
Yours sincerely,
Yasir Shaikh
-------------------------------------------------------------------
This is an Official Information request made via the FYI website.
Please use this email address for all replies to this request:
[FOI #29139 email]
Is [Ministry of Health request email] the wrong address for Official Information requests
to Ministry of Health? If so, please contact us using this form:
[7]https://aus01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[8]https://aus01.safelinks.protection.outlo...
If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.
-------------------------------------------------------------------
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
References
Visible links
1. mailto:[email address]
mailto:[email address]
2. mailto:[email address]
mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
4. mailto:[email address]
mailto:[email address]
5. mailto:[email address]
mailto:[email address]
6. https://www.health.govt.nz/about-ministr...
7. https://fyi.org.nz/change_request/new?bo...
8. https://fyi.org.nz/help/officers
hide quoted sections
From: hnzOIA
Tēnā koe,
Thank you for contacting Health NZ, Te Whatu Ora. This is an automatic
reply to confirm that we have received your email. Depending on the
nature of your request you may not receive a response for up to 20 working
days. We will try to respond to your query as quickly as possible.
Ngā mihi
Health NZ, Te Whatu Ora.
Statement of confidentiality: This email message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege. If you are not the intended recipient, do not read, use,
disseminate, distribute or copy this message or attachments. If you have
received this message in error, please notify the sender immediately and
delete this message
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this request